36745826313_86e4ffa6ac_b

New Johnson & Johnson study aiming to add stroke detection to Apple Watch

February 26, 2020
Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke

Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …

scotland

Scotland’s life sciences sector on track to break $8 billion by 2025

February 25, 2020
Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma

A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …

peoples_assembly_20150620

Austerity policies blamed as English life expectancy stalls for first time in a century

February 25, 2020
Manufacturing and Production England, NHS England, UCL, austerity, life expectancy

A landmark report has shown that English life expectancy has stalled for the first time in a century, and reversed …

FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol

February 25, 2020
Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma

Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …

homoopathie-globuli-naturopathy-naturopaths-homeopathy-beads-royalty-free-thumbnail

World’s second largest API company to be created by Sanofi

February 25, 2020
Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi

Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …

26682732344_ae569bf0e3_b

US domestic supply of 150 drugs under threat from coronavirus outbreak

February 25, 2020
Manufacturing and Production MERS, Sars, US, US Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

Disruption to the US drug production pipeline from the coronavirus could hurt its domestic supply of 150 drugs. US senators …

160x100

2020 Veeva Unified Clinical Operations Survey

February 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …

holly_springs_9frontflags

FDA approves first adjuvanted quadrivalent flu vaccine in over-65s

February 24, 2020
Sales and Marketing FDA, flu, influenza, pharma, seqirus

The FDA has just authorised its first adjuvanted quadrivalent influenza vaccine, it has been announced. Seqirus’ Fluad Quadrivalent (influenza vaccine, adjuvanted) …

shutterstock_212035546

Clover Biopharmaceuticals partners up with GSK to accelerate coronavirus vaccine development

February 24, 2020
Sales and Marketing China, Clover Biopharmaceuticals, GSK, coronavirus, pharma

Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …

lilly_entrance_web

Eli Lilly’s Trulicity approved in US to reduce cardiovascular events in type 2 diabetes patients

February 24, 2020
Sales and Marketing Eli Lilly, Trulicity, cardiovascular disease, pharma

Eli Lilly’s Trulicity (duraglutide) has been awarded marketing authorisation from the FDA as a therapy to reduce major adverse cardiovascular …

Lundbeck’s Vyepti secures US approval for migraine prevention

February 24, 2020
Sales and Marketing FDA, Lundbeck, Vyepti, migraine, pharma

Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention of migraine in adult patients. …

fdaoutsideweb

FDA approval for Baudax Bio’s non-opioid painkiller Anjeso

February 24, 2020
Sales and Marketing Anjeso, FDA, opioids, pharma

Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …

shutterstock_512649

Merck KGaA to flog Allergopharma business to Dermapharm

February 21, 2020
Medical Communications, Sales and Marketing Allergopharma, Dermapharm, Merck KGaA, pharma

German-based drugmaker Merck KGaA has confirmed its intention to divest its allergy business Allergopharma to Dermapharm, another German manufacturer of …

francesa

Teva’s Austedo fails in two paediatric Tourette’s syndrome trials

February 21, 2020
Medical Communications, Research and Development Austedo, Teva, pharma, tourette's

Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

February 21, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …

11295452946_07757c70a8_b

Ukrainian protestors attack bus carrying Chinese evacuees from Wuhan

February 21, 2020
Medical Communications Chinese Coronavirus, MERS, Sars, Wuhan, Wuhan Coronavirus, coronavirus

On Thursday, Ukrainian protestors attacked buses carrying people evacuated from Wuhan in China, the epicenter of the coronavirus outbreak. The …

various-capsules-cure-doctor-thumb

New antibiotic discovered by AI for the first time

February 21, 2020
Medical Communications AI, AI Clinical Trials, AI Drugs, AI antibiotics, MIT, algorithm, clinical trials

MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …

merckincweb

New Keytruda dosing schedule rejected in six cancers by the FDA

February 20, 2020
Sales and Marketing Cancer, FDA, MSD, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda has been stopped in its tracks by the FDA after the US regulator rejected its application …

4353113087_4d19c3a402_b

Bristol-Myers Squibb demonstrates potential for long-term survival in kidney cancer patients treated with Opdivo plus Yervoy

February 20, 2020
Business Services Cancer, Cancers, Yervoy, opdivo, renacl cell carcinoma, renal cancer

Bristol-Myers Squibb has announced updated results from trialing Opdivo (nivolumab) plus Yervoy (ipilimumab) versus sunitinib in patients with previously untreated …

6188261_7290590b

GlaxoSmithKline acquires two solid tumor cell therapies from Immatics for $50 million

February 20, 2020
Business Services Cancer, cancer cells, celluar immunotherapies, immunotherapies

GlaxoSmithKline has struck a deal to access two Immatics T-cell receptor (TCR) therapeutics. The deal sees GSK pay $50 million …

The Gateway to Local Adoption Series

Latest content